相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Angiogenesis inhibitors in the treatment of lung cancer
Sophie Sun et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2007)
Predictors of prophylactic bilateral salpingo-oophorectomy compared with gynecologic screening use in BRCA1/2 mutation carriers
Joanna B. Madalinska et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Sorafenib in advanced clear-cell renal-cell carcinoma
Bernard Escudier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Minireview: RET/PTC rearrangements and BRAF mutations in thyroid tumorigenesis
Raffaele Ciampi et al.
ENDOCRINOLOGY (2007)
Cancer statistics, 2007
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2007)
Hypothyroidism after sunitinib treatment for patients with gastrointestinal stromal tumors
Jayesh Desai et al.
ANNALS OF INTERNAL MEDICINE (2006)
Inhibition of tumor endothelial ERK activation, angiogenesis, and tumor growth by sorafenib (BAY43-9006)
Danielle A. Murphy et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Real-time prognosis for metastatic thyroid carcinoma based on 2-[18F]fluoro-2-deoxy-D-glucose-positron emission tomography scanning
RJ Robbins et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer
MZ Xing et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Mutations of the BRAF gene in papillary thyroid carcinoma in a Korean population
KH Kim et al.
YONSEI MEDICAL JOURNAL (2004)
BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis
SM Wilhelm et al.
CANCER RESEARCH (2004)
Clinical implication of hot spot BRAF mutation, V599E, in papillary thyroid cancers
H Namba et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Prognostic indicators of outcomes in patients with distant metastases from differentiated thyroid carcinoma
M Shoup et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2003)
A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer
JC Yang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
BRAF mutation in papillary thyroid carcinoma
J Cohen et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Vascular endothelial growth factor monoclonal antibody inhibits growth of anaplastic thyroid cancer xenografts in nude mice
AJ Bauer et al.
THYROID (2002)
Mutations of the BRAF gene in human cancer
H Davies et al.
NATURE (2002)
Prevalence of RET/PTC rearrangements in Hashimoto's thyroiditis and papillary thyroid carcinomas
MN Nikiforova et al.
INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY (2002)
分享论文
